";s:4:"text";s:4448:" These 3 patients eventually recovered and all patients were alive on long‐term follow‐up (median = 6.5 yr, range = 2.1‐10.2) after CP.
While most of our patients were given intravenous acyclovir, those treated with oral acyclovir were successfully managed in the outpatient setting. 2.3.4 Togavirus‐like particles For acute hepatitis by herpes simplex virus (HSV) infections, therapeutic options are available with aciclovir [84] [85][86][87][88][89].
All 4 patients received 1 dose of varicella‐zoster immunoglobulin immediately after the exposure. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 Hepatitis B Guidance. All CP infections were cutaneous, with no evidence of organ involvement. The owner of this site is using Wordfence to manage access to their site.You can also read the documentation to learn about Wordfence's blocking tools, or visit wordfence.com to learn more about Wordfence. Northwestern Memorial Hospital, Feinberg School of Medicine, Department of Medicine, Division of Hepatology, Chicago, ILDepartment of Medicine, Division of Infectious Disease, Omaha, NEDepartment of Preventive and Societal Medicine, Section of Biostatistics, Omaha, NEUniversity of Nebraska School of Medicine, Omaha, NEDepartment of Medicine, Division of Infectious Disease, Omaha, NENorthwestern Memorial Hospital, Feinberg School of Medicine, Department of Medicine, Division of Hepatology, Chicago, ILDepartment of Medicine, Division of Infectious Disease, Omaha, NEDepartment of Preventive and Societal Medicine, Section of Biostatistics, Omaha, NEUniversity of Nebraska School of Medicine, Omaha, NEDepartment of Medicine, Division of Infectious Disease, Omaha, NEPresented at the American Transplant Congress, Seattle, WA, May 2005.Use the link below to share a full-text version of this article with your friends and colleagues. : Epstein-Barr virus (EBV) infection frequently involves the liver, presenting as elevations in transaminases.
17. Efficacy trial in healthy childrenEfficacy and safety of immunization for pre‐ and post‐liver transplant childrenAn economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipientsVaricella vaccine in children requiring renal or hepatic transplantationResponse to varicella immunization in pediatric liver transplant recipientsVaricella infection following varicella vaccination in a liver transplant recipientVaccination in adult liver transplantation candidates and recipients, Clinics and Research in Hepatology and Gastroenterology, Principles and Practice of Pediatric Infectious Diseases, Successful rescue of disseminated varicella infection with multiple organ failure in a pediatric living donor liver transplant recipient: a case report and literature review, Infections in Pediatric Solid Organ Transplant Recipients, Journal of the Pediatric Infectious Diseases Society, Varicella Zoster Virus Disease After Pediatric Living Donor Liver Transplantation: Is It Serious?, Fulminant Multiorgan Failure Due to Varicella Zoster Virus and HHV6 in an Immunocompetent Adult Patient, and Anhepatia, Aciclovir and Varicella-zoster-immunoglobulin in solid-organ transplant recipients, Update on infectious diseases in pediatric solid organ transplantation, Incidence and Clinical Characteristics of Herpes Zoster After Lung Transplantation,
Second, because of the small sample size, we chose few variables for our risk factor and outcome analysis. Bacterial superinfections at the time of CP, in particular group A beta‐hemolytic streptococci, may be serious and can be reduced by universal varicella vaccination.The use of varicella vaccine has been very effective in immunizing healthy children and is the standard of care for patients >12 months of age.There are limitations of our study.